Cisplatin nephrotoxicity: new insights and therapeutic implications
C Tang, MJ Livingston, R Safirstein… - Nature Reviews …, 2023 - nature.com
Cisplatin is an effective chemotherapeutic agent for various solid tumours, but its use is
limited by adverse effects in normal tissues. In particular, cisplatin is nephrotoxic and can …
limited by adverse effects in normal tissues. In particular, cisplatin is nephrotoxic and can …
Advances in our understanding of the molecular mechanisms of action of cisplatin in cancer therapy
Cisplatin and other platinum-based chemotherapeutic drugs have been used extensively for
the treatment of human cancers such as bladder, blood, breast, cervical, esophageal, head …
the treatment of human cancers such as bladder, blood, breast, cervical, esophageal, head …
Legumain promotes tubular ferroptosis by facilitating chaperone-mediated autophagy of GPX4 in AKI
C Chen, D Wang, Y Yu, T Zhao, N Min, Y Wu… - Cell death & …, 2021 - nature.com
Legumain is required for maintenance of normal kidney homeostasis. However, its role in
acute kidney injury (AKI) is still unclear. Here, we induced AKI by bilateral ischemia …
acute kidney injury (AKI) is still unclear. Here, we induced AKI by bilateral ischemia …
Cisplatin nephrotoxicity: a review of the literature
Cisplatin is a platinum containing drug first approved as an antineoplastic agent in 1978. It
remains an important and effective therapy in many forms of cancer today. Cisplatin …
remains an important and effective therapy in many forms of cancer today. Cisplatin …
Molecular mechanisms of cisplatin-induced nephrotoxicity: a balance on the knife edge between renoprotection and tumor toxicity
V Volarevic, B Djokovic, MG Jankovic… - Journal of biomedical …, 2019 - Springer
Background Cisplatin (cis-diamminedichloroplatinum II, CDDP) is one of the most effective
chemotherapeutic agents. However, its clinical use is limited due to the severe side effects …
chemotherapeutic agents. However, its clinical use is limited due to the severe side effects …
Pathophysiology of cisplatin‐induced acute kidney injury
A Ozkok, CL Edelstein - BioMed research international, 2014 - Wiley Online Library
Cisplatin and other platinum derivatives are the most widely used chemotherapeutic agents
to treat solid tumors including ovarian, head and neck, and testicular germ cell tumors. A …
to treat solid tumors including ovarian, head and neck, and testicular germ cell tumors. A …
[HTML][HTML] AKI on CKD: heightened injury, suppressed repair, and the underlying mechanisms
L He, Q Wei, J Liu, M Yi, Y Liu, H Liu, L Sun, Y Peng… - Kidney international, 2017 - Elsevier
Acute kidney injury (AKI) and chronic kidney disease (CKD) are interconnected. Although
AKI-to-CKD transition has been intensively studied, the information of AKI on CKD is very …
AKI-to-CKD transition has been intensively studied, the information of AKI on CKD is very …
[HTML][HTML] Pathophysiology of acute kidney injury
DP Basile, MD Anderson, TA Sutton - Comprehensive Physiology, 2012 - ncbi.nlm.nih.gov
Acute kidney injury (AKI) is the leading cause of nephrology consultation and is associated
with high mortality rates. The primary causes of AKI include ischemia, hypoxia or …
with high mortality rates. The primary causes of AKI include ischemia, hypoxia or …
Mechanisms of cisplatin nephrotoxicity
Cisplatin is a widely used and highly effective cancer chemotherapeutic agent. One of the
limiting side effects of cisplatin use is nephrotoxicity. Research over the past 10 years has …
limiting side effects of cisplatin use is nephrotoxicity. Research over the past 10 years has …